ea0081ep510 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022
Abdillahi Mohamed Hamid
, Boutheina Mohamed Ali
, Mohamed Aicha Ahmed
, Rifai Kaoutar
, Gharbi Mh
Introduction: Liraglutide is a glucagon-like peptide 1 (GLP-1) receptor agonist, approved for the treatment of adult patients with type 2 diabetes mellitus of a particular interest in the significant improvement of glycaemic, systolic blood pressure and lipid control with their impact on weight, making it possible to avoid this infernal spiral of weight gain-increased insulin resistance.Observation: 55-year-old female patient, known diabetic for 10 years...